Continuous versus intermittent infusion of polymyxin B in the treatment of infections caused by multidrug-resistant Gram-negative bacteria

International Journal of Antimicrobial Agents

Volumn 31, Issue 1, 2008, Pages 80-82

  Teng, Christine B ^a   Koh, Peai T ^a   Lye, David C B ^a   Ang, Brenda S ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; POLYMYXIN B;

ACINETOBACTER BAUMANNII; ADULT; AGED; AREA UNDER THE CURVE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; LETTER; MALE; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; POLYMYXIN B;

EID: 36949033364     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.08.004     Document Type: Letter

References (7)

1. Package insert. Polymyxin B sulfate sterile, 500,000 units. Bedford, OH: Bedford Laboratories; 2005.
2. Li J., Nation R.L., Milne R.W., Turnidge J.D., and Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 25 (2005) 11-25
3. Tam V.H., Schilling A.N., Vo G., et al. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa. Antimicrob Agents Chemother 49 (2005) 3624-3630
4. Evans M.E., Feola D.J., and Rapp R.P. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria. Ann Pharmacother 33 (1999) 960-967
5. Holloway K.P., Rouphael N.G., Wells J.B., King M.D., and Blumberg H.M. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit. Ann Pharmacother 40 (2006) 1939-1945
6. Ouderkirk J.P., Nord J.A., Turett G.S., and Kislak J.W. Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant Gram-negative bacteria. Antimicrob Agents Chemother 47 (2003) 2659-2662
7. Sobieszczyk M.E., Furuya E.Y., Hay C.M., et al. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections. J Antimicrob Chemother 54 (2004) 566-569